Previous Article
Prometic reports fourth quarter and 2018 year-end financial results
Prometic reports fourth quarter and 2018 year-end financial results

Total revenues for 2018 of $47.4 million compared to $39.1 million in 2017 Significant increase in biosepa...

Next Flipbook
Quarterly Report 2018 Q3
Quarterly Report 2018 Q3

Successful Type C meeting with FDA: agreement on proposed plan of action for RyplazimTM (plasminogen) manuf...